S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end

NeuroPace (NPCE) Earnings Date, Estimates & Call Transcripts

$13.98
-0.02 (-0.14%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 8
After Market Closes
Confirmed
Actual EPS
(Mar. 5)
-$0.23 Beat By $0.10
Consensus EPS
(Mar. 5)
-$0.33
Skip Charts & View Estimated and Actual Earnings Data

NPCE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NPCE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NeuroPace Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241($0.26)($0.26)($0.26) 
Q2 20241($0.28)($0.28)($0.28) 
Q3 20241($0.29)($0.29)($0.29) 
Q4 20241($0.29)($0.29)($0.29) 
FY 20244($1.12)($1.12)($1.12) 
Q1 20251($1.25)($1.25)($1.25) 
Q2 20251($0.85)($0.85)($0.85) 
Q3 20251($0.29)($0.29)($0.29) 
Q4 20251$0.28$0.28$0.28 
FY 20254($2.11)($2.11) ($2.11)

NPCE Earnings Date and Information

NeuroPace last issued its earnings data on March 5th, 2024. The reported ($0.23) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.10. The business earned $18.01 million during the quarter, compared to analyst estimates of $17.74 million. NeuroPace has generated ($1.28) earnings per share over the last year (($1.28) diluted earnings per share). Earnings for NeuroPace are expected to decrease in the coming year, from ($1.14) to ($1.15) per share. NeuroPace has confirmed that its next quarterly earnings report will be published on Wednesday, May 8th, 2024. NeuroPace will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

NeuroPace Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Confirmed)
-------  
3/5/2024Q4 2023($0.33)($0.23)+$0.10($0.23)$17.74 million$18.01 million    
11/6/2023Q3 2023($0.39)($0.28)+$0.11($0.28)$14.23 million$16.43 million
8/8/2023Q2 2023($0.47)($0.36)+$0.11($0.36)$12.74 million$16.51 million
5/4/2023Q1 2023($0.46)($0.41)+$0.05($0.41)$12.04 million$14.47 million
3/2/2023Q4 2022($0.49)($0.45)+$0.04($0.45)-$12.79 million
11/8/2022Q3 2022($0.52)($0.48)+$0.04($0.48)$10.32 million$11.16 million    
8/11/2022Q2 2022($0.44)($0.52)($0.08)($0.52)$10.61 million$10.20 million
5/12/2022Q1 2022($0.46)($0.47)($0.01)($0.47)$10.45 million$11.37 million
3/10/2022Q4 2021($0.33)($0.44)($0.11)($0.44)$11.00 million$11.00 million    
11/10/2021Q3 2021($0.30)($0.34)($0.04)($0.34)$10.74 million$10.34 million    
8/12/2021Q2 2021($0.39)($0.48)($0.09)($0.24)$11.49 million$12.63 million    
6/3/2021Q1 2021($0.25)($21.21)($20.96)($9.69)$10.99 million$11.22 million

NeuroPace Earnings - Frequently Asked Questions

When is NeuroPace's earnings date?

NeuroPace has confirmed that its next quarterly earnings data will be published on Wednesday, May 8th, 2024. Learn more on NPCE's earnings history.

Did NeuroPace beat their earnings estimates last quarter?

In the previous quarter, NeuroPace (NASDAQ:NPCE) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.33) by $0.10. Learn more on analysts' earnings estimate vs. NPCE's actual earnings.

How can I listen to NeuroPace's earnings conference call?

The conference call for NeuroPace's latest earnings report can be listened to online. Listen to Conference Call

How can I read NeuroPace's conference call transcript?

The conference call transcript for NeuroPace's latest earnings report can be read online. Read Transcript

How much revenue does NeuroPace generate each year?

NeuroPace (NASDAQ:NPCE) has a recorded annual revenue of $65.42 million.

How much profit does NeuroPace generate each year?

NeuroPace (NASDAQ:NPCE) has a recorded net income of -$32.96 million. NPCE has generated -$1.28 earnings per share over the last four quarters.

What is NeuroPace's EPS forecast for next year?

NeuroPace's earnings are expected to decrease from ($1.14) per share to ($1.15) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:NPCE) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners